FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Life (Basel, Switzerland)2022; 12(12); doi: 10.3390/life12122135

Antibiofilm Activity of Weissella spp. and Bacillus coagulans Isolated from Equine Skin against Staphylococcus aureus.

Abstract: The aim of this study was to evaluate the antimicrobial and antibiofilm activity of Weissella cibaria, Weissella hellenica and Bacillus coagulans, isolated from equine skin, against biofilm-forming Staphylococcus aureus CCM 4223 and clinical isolate methicillin-resistant S. aureus (MRSA). Non-neutralized cell-free supernatants (nnCFS) of tested skin isolates completely inhibited the growth and biofilm formation of S. aureus strains and caused dispersion of the 24 h preformed biofilm in the range of 21-90%. The majority of the pH-neutralized cell-free supernatants (nCFS) of skin isolates inhibited the biofilm formation of both S. aureus strains in the range of 20-100%. The dispersion activity of B. coagulans nCFS ranged from 17 to 77% and was significantly lower than that of nnCFS, except for B. coagulans 3T27 against S. aureus CCM 4223. Changes in the growth of S. aureus CCM 4223 in the presence of catalase- or trypsin-treated W. hellenica 4/2D23 and W. cibaria 4/8D37 nCFS indicated the role of peroxides and/or bacteriocin in their antimicrobial activities. For the first time, the presence of the fenD gene, associated with biosurfactants production, was detected in B. coagulans. The results of this study showed that selected isolates may have the potential for the prevention and treatment of biofilm-forming S. aureus infections.
Get Full Text
Publication Date: 2022-12-17 PubMed ID: 36556500PubMed Central: PMC9787530DOI: 10.3390/life12122135Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper details a study aimed at investigating the potential antimicrobial and antibiofilm properties of bacteria, Weissella cibaria, Weissella hellenica and Bacillus coagulans, extracted from equine skin, when pitted against Staphylococcus aureus, a common bacterium responsible for a range of diseases in humans.

Research Objectives

  • The main objective of the study was to ascertain the antibacterial and antibiofilm properties of bacteria Weissella cibaria, Weissella hellenica, and Bacillus coagulans, specifically isolated from horse skin.
  • These characteristics were evaluated against Staphylococcus aureus CCM 4223 and a clinically isolated strain of methicillin-resistant Staphylococcus aureus (MRSA).

Research Methodology

  • The researchers used nnCFS (non-neutralized cell-free supernatants) of the skin-isolated organisms to evaluate the inhibition and dispersion of S. aureus growth and biofilm formation.
  • The effects of pH-neutralized cell-free supernatants (nCFS) were also explored for the same purpose.
  • The study additionally involved examining growth changes in S. aureus CCM 4223 when exposed to catalase- or trypsin-treated W. hellenica 4/2D23 and W. cibaria 4/8D37 nCFS, to establish the role of peroxides and/or bacteriocin in these bacteria’s antimicrobial activity.

Key Findings

  • The nnCFS of tested skin isolates completely inhibited the growth and biofilm formation of S. aureus strains and dispersed the 24 h preformed biofilm by 21-90%.
  • The majority of nCFS of skin isolates obstructed the biofilm formation of both S. aureus strains by 20-100%.
  • The dispersion activity of B. coagulans nCFS ranged from 17% to 77%, although this was significantly lower than nnCFS, apart from against S. aureus CCM 4223.
  • The presence of the fenD gene, associated with biosurfactants production, was detected in B. coagulans for the first time.
  • The results indicate that selected isolates may be effective in preventing and treating biofilm-forming S. aureus infections.

Cite This Article

APA
Styková E, Nemcová R, Maďar M, Bujňáková D, Mucha R, Gancarčíková S, Requena Domenech F. (2022). Antibiofilm Activity of Weissella spp. and Bacillus coagulans Isolated from Equine Skin against Staphylococcus aureus. Life (Basel), 12(12). https://doi.org/10.3390/life12122135

Publication

Life (Basel, Switzerland)
ISSN: 2075-1729
NlmUniqueID: 101580444
Country: Switzerland
Language: English
Volume: 12
Issue: 12

Researcher Affiliations

Styková, Eva
  • Clinic of Horses, University Veterinary Hospital, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia.
Nemcová, Radomíra
  • Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia.
Maďar, Marián
  • Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia.
Bujňáková, Dobroslava
  • Institute of Animal Physiology, Centre of Biosciences of the Slovak Academy of Sciences, Šoltésovej 4, 040 01 Košice, Slovakia.
Mucha, Rastislav
  • Institute of Neurobiology, Biomedical Research Center of the Slovak Academy of Sciences, Šoltésovej 4, 040 01 Košice, Slovakia.
Gancarčíková, Soňa
  • Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81 Košice, Slovakia.
Requena Domenech, Francisco
  • Department of Cell Biology, Physiology and Immunology, University of Córdoba, 14014 Córdoba, Spain.

Grant Funding

  • APVV-16-0203 / Slovak Research and Development Agency
  • VEGA 1/0372/22 / Ministry of Education, Science, Research and Sport of the Slovak Republic

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 94 references
  1. Donlan R.M., Costerton J.W.. Biofilms, survival mechanisms of clinically relevant microorganisms.. Clin. Microbiol. Rev. 2002;15:167–193.
    doi: 10.1128/CMR.15.2.167-193.2002pmc: PMC118068pubmed: 11932229google scholar: lookup
  2. Thomas J., Narkowicz C., Peterson G.M., Jacobson G.A., Narayana A.. Treatment of pastern dermatitis with a formulation containing kunzea oil: A randomised controlled trial.. Vet. Rec. 2009;20:619–623.
    doi: 10.1136/vr.164.20.619pubmed: 19448254google scholar: lookup
  3. Hughes G., Webber M.A.. Novel approaches to the treatment of bacterial biofilm infections.. Br. J. Pharmacol. 2017;174:2237–2246.
    doi: 10.1111/bph.13706pmc: PMC5481657pubmed: 28063237google scholar: lookup
  4. Cinque B., La Torre C., Melchiorre E., Marchesani G., Zoccali G., Palumbo P., Di Marzio L., Masci A., Mosca L., Mastromarino P.. Use of probiotics for dermal applications.. Probiotics 2011. pp. 221–241.
  5. Lee K.W., Park J.Y., Jeong H.R., Heo H.J., Han N.S., Kim J.H.. Probiotic properties of Weissella strains isolated from human faeces.. Anaerobe 2012;18:96–102.
    doi: 10.1016/j.anaerobe.2011.12.015pubmed: 22200451google scholar: lookup
  6. Lew L.C., Liong M.T.. Bioactives from probiotics for dermal health: Functions and benefits.. J. Appl. Microbiol. 2013;114:1241–1253.
    doi: 10.1111/jam.12137pubmed: 23311666google scholar: lookup
  7. Gillor O., Etzion A., Riley M.A.. The dual role of bacteriocins as anti- and probiotics.. Appl. Microbiol. Biotechnol. 2008;81:591–606.
    doi: 10.1007/s00253-008-1726-5pmc: PMC2670069pubmed: 18853155google scholar: lookup
  8. Ouwehand A.C., Tiihonen K., Lahtinen S.. The potential of probiotics and prebiotics for skin health.. Textbook of Aging Skin 2010.
  9. Fusco V., Quero G.M., Stea G., Morea M., Visconti A.. Novel PCR-based identification of Weissella confusa using an AFLP-derived marker.. Int. J. Food Microbiol. 2011;145:437–443.
    doi: 10.1016/j.ijfoodmicro.2011.01.015pubmed: 21296447google scholar: lookup
  10. Abdhul K., Ganesh M., Shanmughapriya S., Vanithamani S., Kanagavel M., Anbarasu K., Natarajaseenivasan K.. Bacteriocinogenic potential of a probiotic strain Bacillus coagulans [BDU3] from Ngari.. Int. J. Biol. Macromol. 2015;79:800–806.
    doi: 10.1016/j.ijbiomac.2015.06.005pubmed: 26054664google scholar: lookup
  11. Konuray G., Erginkaya Z.. Potential Use of Bacillus coagulans in the food industry.. Foods 2018;7:92.
    doi: 10.3390/foods7060092pmc: PMC6025323pubmed: 29899254google scholar: lookup
  12. Spigelman M., Ross M.. Method of Using Topical Probiotics for the Inhibition of Surface Contamination by a Pathogenic Microorganisms and Composition Therefor.. U.S. Patent 2008 May 8.
  13. Kang M.S., Chung J., Kim S.M., Yang K.H., Oh J.S.. Effect of Weissella cibaria isolates on the formation of Streptococcus mutans biofilm.. Caries Res. 2006;40:418–425.
    doi: 10.1159/000094288pubmed: 16946611google scholar: lookup
  14. Jang H.J., Kang M.S., Yi S.H., Hong J.Y., Hong S.P.. Comparative study on the characteristics of Weissella cibaria CMU and probiotic strains for oral care.. Molecules 2016;21:1752.
    doi: 10.3390/molecules21121752pmc: PMC6274271pubmed: 27999400google scholar: lookup
  15. Lim H.S., Yeu J.E., Hong S.P., Kang M.S.. Characterization of antibacterial cell-free supernatant from oral care probiotic Weissella cibaria, CMU.. Molecules 2018;23:1984.
    doi: 10.3390/molecules23081984pmc: PMC6222630pubmed: 30096901google scholar: lookup
  16. Subsanguan T., Khondee N., Nawavimarn P., Rongsayamanont W., Chen C.Y., Luepromchai E.. Reuse of immobilized Weissella cibaria PN3 for long-term production of both extracellular and cell-bound glycolipid biosurfactants.. Front. Bioeng. Biotechnol. 2020;8:751.
    doi: 10.3389/fbioe.2020.00751pmc: PMC7347796pubmed: 32719789google scholar: lookup
  17. Yu A.A.. Equine Pastern Dermatitis.. Vet. Clin. North. Am. Equine Pract. 2013;29:577–588.
    doi: 10.1016/j.cveq.2013.09.003pubmed: 24267676google scholar: lookup
  18. Akucewich L., Yu A.A.. Equine pastern dermatitis.. Compend. Equine Ed. 2007;2:214–228.
  19. Kaiser-Thom S., Hilty M., Axiak S., Gerber V.. The skin microbiota in equine pastern dermatitis: A case-control study of horses in Switzerland.. Vet Dermatol. 2021;32:646–e172.
    doi: 10.1111/vde.12955pmc: PMC9290916pubmed: 33830562google scholar: lookup
  20. Lory S.. The family Staphylococcaceae.. The Prokaryotes 2014. pp. 363–366.
  21. Wolcott R.D., Hanson J.D., Rees E.J., Koenig L.D., Phillips C.D., Wolcott R.A., Cox S.B., White J.S.. Analysis of the chronic wound microbiota of 2963 patients by 16S rDNA pyrosequencing.. Wound Repair Regen. 2016;24:163–174.
    doi: 10.1111/wrr.12370pubmed: 26463872google scholar: lookup
  22. Dowd S.E., Sun Y., Secor P.R., Rhoads D.D., Wolcott B.M., James G.A., Wolcott R.D.. Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing.. BMC Microbiol. 2008;8:43.
    doi: 10.1186/1471-2180-8-43pmc: PMC2289825pubmed: 18325110google scholar: lookup
  23. Chiers K., Decostere A., Devriese L.A., Haesebrouck F.. Bacteriological and mycological findings, and in vitro antibiotic sensitivity of pathogenic staphylococci in equine skin infections.. Vet. Rec. 2003;152:138–141.
    doi: 10.1136/vr.152.5.138pubmed: 12585601google scholar: lookup
  24. Vincze S., Stamm I., Kopp P.A., Hermes J., Adlhoch C., Semmler T., Wieler L.H., Lübke-Becker A., Walther B.. Alarming proportions of methicillin-resistant Staphylococcus aureus (MRSA) in wound samples from companion animals, Germany 2010–2012.. PLoS ONE 2014;9:e85656.
    doi: 10.1371/journal.pone.0085656pmc: PMC3896405pubmed: 24465637google scholar: lookup
  25. Frank J.A., Reich C.I., Sharma S., Weisbaum J.S., Wilson B.A., Olsen G.J.. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes.. Appl. Environ. Microbiol. 2008;74:2461–2470.
    doi: 10.1128/AEM.02272-07pmc: PMC2293150pubmed: 18296538google scholar: lookup
  26. . Milk and Milk Products-Determination of Minimal Inhibitory Concentration (MIC) of Antibiotic Applicable to Bifidobacteria and Non-Enterococcal Lactic Acid Bacteria (LAB). International Organization for Standardization 2010.
  27. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance.. EFSA J. 2012;10:2740.
  28. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Guidance on the characterization of microorganisms used as feed additives or as production organisms.. EFSA J. 2018;16:5206.
    pubmed: 0
  29. Lin X., Chen X., Chen Y., Jiang W., Chen H.. The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans.. Oral Dis. 2015;21:128–134.
    doi: 10.1111/odi.12257pubmed: 24806217google scholar: lookup
  30. Styková E., Nemcová R., Gancarčíková S., Valocký I., Lauková A.. Bovine vaginal lactobacilli and their adherence to mucus in different phases of the estrous cycle.. Afr. J. Microbiol. Res. 2014;8:3017–3024.
    doi: 10.5897/AJMR2014.6886google scholar: lookup
  31. Englerová K., Bedlovičová Z., Nemcová R., Király J., Maďar M., Hajdučková V., Styková E., Mucha R., Reiffová K.. Bacillus amyloliqiens-derived lipopeptide biosurfactants inhibit biofilm formation and expression of biofilm-related genes of Staphylococcus aureus.. Antibiotics 2021;10:1252.
    doi: 10.3390/antibiotics10101252pmc: PMC8532693pubmed: 34680832google scholar: lookup
  32. O’ Toole G.A., Pratt L.A., Watnick P.I., Newman D.K., Weaver V.B., Kolter R.. Genetic approaches to study of biofilms.. Methods Enzymol. 1999;310:91–109.
    doi: 10.1016/s0076-6879(99)10008-9pubmed: 10547784google scholar: lookup
  33. Kaur S., Sharma P., Kalia N., Singh J., Kaur S.. Anti-biofilm properties of the fecal probiotic lactobacilli against Vibrio spp.. Front. Cell. Infect. Microbiol. 2018;8:120.
    doi: 10.3389/fcimb.2018.00120pmc: PMC5928150pubmed: 29740541google scholar: lookup
  34. Wasfi R., Abd El-Rahman O.A., Zafer M.M., Ashour H.M.. Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans.. J. Cell. Mol. Med. 2018;22:1972–1983.
    doi: 10.1111/jcmm.13496pmc: PMC5824418pubmed: 29316223google scholar: lookup
  35. Morikawa M., Hirata Y., Imanaka T.. A study on the structure-function relationship of lipopeptide biosurfactants.. Biochim. Biophys. Acta. 2000;1488:211–218.
    doi: 10.1016/S1388-1981(00)00124-4pubmed: 11082531google scholar: lookup
  36. Ghasemi A., Moosavi-Nasab M., Setoodeh P., Mesbahi G., Yousefi G.. Biosurfactant production by lactic acid bacterium Pediococcus dextrinicus SHU1593 grown on different carbon sources: Strain screening followed by product characterization.. Sci. Rep. 2019;9:5287.
    doi: 10.1038/s41598-019-41589-0pmc: PMC6437191pubmed: 30918296google scholar: lookup
  37. Chung S., Kong H., Buyer J.S., Lakshman D.K., Lydon J., Kim S.D., Roberts D.P.. Isolation and partial characterization of Bacillus subtilis ME488 for suppression of soilborne pathogens of cucumber and pepper.. Appl. Microbiol. Biotechnol. 2008;80:115–123.
    doi: 10.1007/s00253-008-1520-4pubmed: 18542950google scholar: lookup
  38. Amruta N., Prasanna Kumar M.K., Puneeth M.E., Sarika G., Kandikattu H.K., Vishwanath K., Narayanaswamy S.. Exploring the potentiality of novel rhizospheric bacterial strains against the rice blast fungus Magnaporthe oryzae.. Plant Pathol. J. 2018;34:126–138.
    doi: 10.5423/PPJ.OA.11.2017.0242pmc: PMC5880357pubmed: 29628819google scholar: lookup
  39. Citron D.M., Appleman M.D.. In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species.. J. Clin. Microbiol. 2006;44:3814–3818.
    doi: 10.1128/JCM.00881-06pmc: PMC1594774pubmed: 17021118google scholar: lookup
  40. Cecchini M., Langer J., Slawomirski L.. Antimicrobial Resistance in G7 Countries and Beyond: Economic Issues, Policies and Options for Action.. OECD Report 2015.
  41. Nakamura Y., Daya M.. Use of appropriate antimicrobials in wound management.. Emerg. Med. Clin. N. Am. 2007;25:159–176.
    doi: 10.1016/j.emc.2007.01.007pubmed: 17400079google scholar: lookup
  42. Mihai M.M., Preda M., Lungu I., Gestal M.C., Popa M.I., Holban A.M.. Nanocoatings for chronic wound repairmodulation of microbial colonization and biofilm formation.. Int. J. Mol. Sci. 2018;19:1179.
    doi: 10.3390/ijms19041179pmc: PMC5979353pubmed: 29649179google scholar: lookup
  43. Walker W.A.. Mechanisms of action of probiotics.. Clin. Infect. Dis. 2008;46:87–91.
    doi: 10.1086/523335pubmed: 18181730google scholar: lookup
  44. Lister J.L., Horswill A.R.. Staphylococcus aureus biofilms: Recent developments in biofilm dispersal.. Front. Cell Infect. Microbiol. 2014;4:178.
    doi: 10.3389/fcimb.2014.00178pmc: PMC4275032pubmed: 25566513google scholar: lookup
  45. Idrees M., Sawant S., Karodia N., Rahman A.. Staphylococcus aureus biofilm: Morphology, genetics, pathogenesis and treatment strategies.. Int. J. Environ. Res. Public Health. 2021;18:7602.
    doi: 10.3390/ijerph18147602pmc: PMC8304105pubmed: 34300053google scholar: lookup
  46. Zhang Z., Peng X., Zhang N., Liu L., Wang Y., Ou S.. Cytotoxicity comparison of quercetin and its metabolites from in vitro fermentation of several gut bacteria.. Food Funct. 2014;5:2152–2156.
    doi: 10.1039/C4FO00418Cpubmed: 25015032google scholar: lookup
  47. Cai Y., Benno Y., Nakase T., Oh T.K.. Specific probiotic characterization of Weissella hellenica DS-12 isolated from flounder intestine.. J. Gen. Appl. Microbiol. 1998;44:311–316.
    doi: 10.2323/jgam.44.311pubmed: 12501410google scholar: lookup
  48. Sun H.Y., Kim K.P., Bae C.H., Choi A.J., Paik H.D., Kim I.H.. Evaluation of Weissella cibaria JW15 probiotic derived from fermented korean vegetable product supplementation in diet on performance characteristics in adult beagle dog.. Animals 2019;9:581.
    doi: 10.3390/ani9080581pmc: PMC6719065pubmed: 31434237google scholar: lookup
  49. Elshaghabee F.M.F., Rokana N., Gulhane R.D., Sharma C., Panwar H.. Bacillus as potential probiotics: Status, concerns, and future perspectives.. Front. Microbiol. 2017;8:1490.
    doi: 10.3389/fmicb.2017.01490pmc: PMC5554123pubmed: 28848511google scholar: lookup
  50. Haldar L., Gandhi D.N.. Effect of oral administration of Bacillus coagulans B37 and Bacillus pumilus B9 strains on fecal coliforms, Lactobacillus and Bacillus spp. in rat animal model.. Vet. World. 2016;9:766–772.
    doi: 10.14202/vetworld.2016.766-772pmc: PMC4983130pubmed: 27536040google scholar: lookup
  51. Harakeh S.M., Khan I., Kumosani T., Barbour E., Almasaudi S.B., Bahijri S.M., Alfadul S.M., Ajabnoor G.M.A., Azhar E.I.. Gut microbiota: A contributing factor to obesity.. Front. Cell. Infect. Microbiol. 2016;6:95.
    doi: 10.3389/fcimb.2016.00095pmc: PMC5003832pubmed: 27625997google scholar: lookup
  52. Jensen G.S., Cash H.A., Farmer S., Keller D.. Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro.. J. Inflamm. Res. 2017;10:107–117.
    doi: 10.2147/JIR.S141660pmc: PMC5557913pubmed: 28848360google scholar: lookup
  53. Flórez A.B., Campedelli I., Delgado S., Alegría Á., Salvetti E., Felis G.E., Mayo B., Torriani S.. Antibiotic susceptibility profiles of dairy Leuconostoc, analysis of the genetic basis of atypical resistances and transfer of genes in vitro and in a food matrix.. PLoS ONE 2016;11:e0145203.
    doi: 10.1371/journal.pone.0145203pmc: PMC4699710pubmed: 26726815google scholar: lookup
  54. Abriouel H., Lerma L.L., Casado Muñoz M.d.C., Montoro B.P., Kabisch J., Pichner R., Cho G.S., Neve H., Fusco V., Franz C.M.. The controversial nature of the Weissella genus: Technological and functional aspects versus whole genome analysis-based pathogenic potential for their application in food and health.. Front. Microbiol. 2015;6:1197.
    doi: 10.3389/fmicb.2015.01197pmc: PMC4621295pubmed: 26579103google scholar: lookup
  55. Ogier J.C., Casalta E., Farrokh C., Saïhi A.. Safety assessment of dairy microorganisms: The Leuconostoc genus.. Int. J. Food Microbiol. 2008;126:286–290.
    doi: 10.1016/j.ijfoodmicro.2007.08.012pubmed: 17897747google scholar: lookup
  56. Hemme D., Foucaud-Scheunemann C.. Leuconostoc, characteristics, use in dairy technology and prospects in functional foods.. Int. Dairy J. 2004;14:467–494.
    doi: 10.1016/j.idairyj.2003.10.005google scholar: lookup
  57. Endres J.R., Clewell A., Jade K.A., Farber T., Hauswirth J., Schauss A.G.. Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient.. Food Chem. Toxicol. 2009;47:1231–1238.
    doi: 10.1016/j.fct.2009.02.018pmc: PMC2726964pubmed: 19248815google scholar: lookup
  58. Lawley R., Curtis L., Davis J.. Use of extracellular extracts of lactic acid bacteria and bifidobacteria for the inhibition of dermatological pathogen Staphylococcus aureus.. The Food Safety Hazard Guidebook 2008. pp. 70–74.
  59. Aween M.M., Hassan Z., Muhialdin B.J., Noor H.M., Eljamel Y.A.. Evaluation on antibacterial activity of Lactobacillus acidophilus strains isolated from honey.. Am. J. Appl. Sci. 2012;9:807–817.
    doi: 10.3844/ajassp.2012.807.817pubmed: 22757710google scholar: lookup
  60. Nagoba B., Wadher B., Kulkarni P., Kolhe S.. Acetic acid treatment of pseudomonas wound infections.. Eur. J. Gen. Med. 2008;5:104–106.
    doi: 10.29333/ejgm/82586google scholar: lookup
  61. Hirshfield I.N., Terzulli S., O’Byrne C.. Weak organic acids: A panoply of effects on bacteria.. Sci. Prog. 2003;86:245–269.
    doi: 10.3184/003685003783238626pmc: PMC10367495pubmed: 15508892google scholar: lookup
  62. Brul S., Coote P.. Preservative agents in foods. Mode of action and microbial resistance mechanisms.. Int. J. Food Microbiol. 1999;50:1–17.
    doi: 10.1016/S0168-1605(99)00072-0pubmed: 10488839google scholar: lookup
  63. Bjarnsholt T., Alhede M., Jensen P.Ø., Nielsen A.K., Johansen H.K., Homøe P., Høiby N., Givskov M., Kirketerp-Møller K.. Antibiofilm properties of acetic acid.. Adv. Wound Care. 2015;4:363–372.
    doi: 10.1089/wound.2014.0554pmc: PMC4486441pubmed: 26155378google scholar: lookup
  64. Halstead F.D., Rauf M., Moiemen N.S., Bamford A., Wearn C.M., Fraise A.P., Lund P.A.. The antibacterial activity of acetic acid against biofilm-producing pathogens of relevance to burns patients.. PLoS ONE 2015;10:e0136190.
    doi: 10.1371/journal.pone.0136190pmc: PMC4566994pubmed: 26352256google scholar: lookup
  65. Juturu V., Wu J.C.. Microbial production of lactic acid: The latest development.. Crit. Rev. Biotechol. 2016;36:967–977.
    doi: 10.3109/07388551.2015.1066305pubmed: 26287368google scholar: lookup
  66. Patel A., Falck P., Shah N., Immerzeel P., Adlercreutz P., Stålbrand H., Prajapati J.B., Holst O., Nordberg Karlsson E.. Evidence for xylooligosaccharide utilization in Weissella strains isolated from Indian fermented foods and vegetables.. FEMS Microbiol. Lett. 2013;346:20–28.
    doi: 10.1111/1574-6968.12191pubmed: 23738850google scholar: lookup
  67. Pelyuntha W., Chaiyasut C., Kantachote D., Sirilun S.. Organic acids and 2,4-Di-tert-butylphenol: Major compounds of Weissella confusa WM36 cell-free supernatant against growth, survival and virulence of Salmonella Typhi.. PeerJ 2020;8:e8410.
    doi: 10.7717/peerj.8410pmc: PMC6977521pubmed: 31998561google scholar: lookup
  68. Majeed M., Nagabhushanam K., Natarajan S., Sivakumar A., Eshuis-de Ruiter T., Booij-Veurink J., de Vries Y.P., Ali F.. Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: A commercial probiotic strain.. World J. Microbiol. Biotechnol. 2016;32:60.
    doi: 10.1007/s11274-016-2027-2pmc: PMC4771827pubmed: 26925622google scholar: lookup
  69. Sui L., Zhu X., Wu D., Ma T., Tuo Y., Jiang S., Qian F., Mu G.. In vitro assessment of probiotic and functional properties of Bacillus coagulans T242.. Food Biosci. 2020;36:100675.
    doi: 10.1016/j.fbio.2020.100675google scholar: lookup
  70. Konuray G., Erginkaya Z.. Identification and characterization of Bacillus coagulans strains for probiotic activity and safety.. LWT 2021;151:112233.
    doi: 10.1016/j.lwt.2021.112233google scholar: lookup
  71. Masuda Y., Zendo T., Sawa N., Honrada Perez R., Nakayama J., Sonomoto K.. Characterization and identification of weissellicin Y and weissellicin M, novel bacteriocins produced by Weissella hellenica QU 13.. J. Appl. Microbiol. 2012;112:99–108.
    doi: 10.1111/j.1365-2672.2011.05180.xpubmed: 22008177google scholar: lookup
  72. Leong K.-H., Chen Y.-S., Lin Y.-H., Pan S.-F., Yu B., Wu H.-C., Yanagida F.. Weissellicin L, a novel bacteriocin from sian-sianzih-isolated Weissella hellenica 4-7.. J. Appl. Microbiol. 2013;115:70–76.
    doi: 10.1111/jam.12218pubmed: 23594122google scholar: lookup
  73. Srionnual S., Yanagida F., Li-Hsiu L., Hsiao K.N., Yi-sheng C.. Weissellicin 110, a newly discovered bacteriocin from Weissella cibaria 110, isolated from plaa-som, a fermented fish product from Thailand.. Appl. Environ. Microb. 2007;73:2247–2250.
    doi: 10.1128/AEM.02484-06pmc: PMC1855655pubmed: 17293526google scholar: lookup
  74. Chen C., Chen X., Jiang M., Rui X., Li W., Dong M.. A newly discovered bacteriocin from Weissella hellenica D1501 associated with Chinese Dong fermented meat (Nanx Wudl.). Food Control. 2014;42:116–124.
    doi: 10.1016/j.foodcont.2014.01.031google scholar: lookup
  75. Endo A., Futagawa-Endo Y., Kawasaki S., Dicks L.M., Niimura Y., Okada S.. Sodium acetate enhances hydrogen peroxide production in Weissella cibaria.. Lett. Appl. Microbiol. 2009;49:136–141.
    doi: 10.1111/j.1472-765X.2009.02633.xpubmed: 19413761google scholar: lookup
  76. Lee Y.. Characterization of Weissella kimchii PL9023 as a potential probiotic for women.. FEMS Microbiol. Lett. 2005;250:157–162.
    doi: 10.1016/j.femsle.2005.07.009pubmed: 16055277google scholar: lookup
  77. Hyronimus B., Le Marrec C., Urdaci M.C.. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4.. J. Appl. Microbiol. 1998;85:42–50.
    doi: 10.1046/j.1365-2672.1998.00466.xpubmed: 9721655google scholar: lookup
  78. Fu L., Wang C., Ruan X., Li G., Zhao Y., Wang Y.. Preservation of large yellow croaker (Pseudosciaena crocea) by Coagulin L1208, a novel bacteriocin produced by Bacillus coagulans L1208.. Int. J. Food Microbiol. 2018;266:60–68.
    doi: 10.1016/j.ijfoodmicro.2017.11.012pubmed: 29179097google scholar: lookup
  79. Tsang S.T.J., Gwynne P.J., Gallagher M.P., Simpson A.H.R.W.. The biofilm eradication activity of acetic acid in the management of periprosthetic joint infection.. Bone Joint Res. 2018;7:517–523.
    doi: 10.1302/2046-3758.78.BJR-2018-0045.R1pmc: PMC6138806pubmed: 30258571google scholar: lookup
  80. Lund P., Tramonti A., De Biase D.. Coping with low pH: Molecular strategies in neutralophilic bacteria.. FEMS Microbiol. Rev. 2014;38:1091–1125.
    doi: 10.1111/1574-6976.12076pubmed: 24898062google scholar: lookup
  81. Peetermans A., Foulquié–Moreno M.R., Thevelein J.M.. Mechanisms underlying lactic acid tolerance and its influence on lactic acid production in Saccharomyces cerevisiae.. Microbial Cell. 2021;8:111–130.
    doi: 10.15698/mic2021.06.751pmc: PMC8144909pubmed: 34055965google scholar: lookup
  82. Piard J.C., Desmazeaud M.. Inhibiting factors produced by lactic acid bacteria.. Lait. 1991;71:525–541.
    doi: 10.1051/lait:1991541google scholar: lookup
  83. Uppuluri P., Chaturvedi A.K., Srinivasan A., Banerjee M., Ramasubramaniam A.K., Köhler J.R., Kadosh D., Lopez-Ribot J.L.. Dispersion as an important step in the Candida albicans biofilm developmental cycle.. PLoS Pathog. 2010;6:e1000828.
    doi: 10.1371/journal.ppat.1000828pmc: PMC2847914pubmed: 20360962google scholar: lookup
  84. Davies D.G., Marques C.N.. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms.. J. Bacteriol. 2009;191:1393–1403.
    doi: 10.1128/JB.01214-08pmc: PMC2648214pubmed: 19074399google scholar: lookup
  85. Rahmani-Badi A., Sepehr S., Babaie-Naiej H.. A combination of cis-2-decenoic acid and chlorhexidine removes dental plaque.. Arch. Oral Biol. 2015;60:1655–1661.
    doi: 10.1016/j.archoralbio.2015.08.006pubmed: 26351749google scholar: lookup
  86. Banat I.M., De Rienzo M.A., Quinn G.A.. Microbial biofilms: Biosurfactants as antibiofilm agents.. Appl. Microbiol. Biotechnol. 2014;98:9915–9929.
    doi: 10.1007/s00253-014-6169-6pubmed: 25359476google scholar: lookup
  87. Mouafo H.T., Sokamte A.T., Mbawala A., Ndjouenkeu R., Devappa S.. Biosurfactants from lactic acid bacteria: A critical review on production, extraction, structural characterization and food application.. Food Biosci. 2022;46:101598.
    doi: 10.1016/j.fbio.2022.101598google scholar: lookup
  88. Huszcza E., Burczyk B.. Biosurfactant production by Bacillus coagulans.. J. Surfact. Deterg. 2003;6:61–64.
    doi: 10.1007/s11743-003-0249-2google scholar: lookup
  89. Cortés-Camargo S., Pérez-Rodríguez N., Pinheiro de Souza Oliveira R., Barragán Huerta B.E., Domínguez J.M.. Production of biosurfactants from vine-trimming shoots using the halotolerant strain Bacillus tequilensis ZSB10.. Ind. Crops Prod. 2016;79:258–266.
    doi: 10.1016/j.indcrop.2015.11.003google scholar: lookup
  90. Plaza G., Chojniak J., Rudnicka K., Paraszkiewicz K., Bernat P.. Detection of biosurfactants in Bacillus species: Genes and products identification.. J. Appl. Microbiol. 2015;119:1023–1034.
    doi: 10.1111/jam.12893pubmed: 26171834google scholar: lookup
  91. Gerayeli N., Baghaee-Ravari S., Tarighi S.. Evaluation of the antagonistic potential of Bacillus strains against Pectobacterium carotovorum subsp. carotovorum and their role in the induction of resistance to potato soft rot infection.. Eur. J. Plant Pathol. 2017;150:1049–1063.
  92. Mora I., Cabrefiga J., Montesinos E.. Cyclic lipopeptide biosynthetic genes and products, and inhibitory activity of plant-associated Bacillus against phytopathogenic bacteria.. PLoS ONE 2015;10:e0127738.
    doi: 10.1371/journal.pone.0127738pmc: PMC4449161pubmed: 26024374google scholar: lookup
  93. Xu Z., Shao J., Li B., Yan X., Shen Q., Zhang R.. Contribution of bacillomycin D in Bacillus amyloliqiens SQR9 to antifungal activity and biofilm formation.. Appl. Environ. Microbiol. 2013;79:808–815.
    doi: 10.1128/AEM.02645-12pmc: PMC3568560pubmed: 23160135google scholar: lookup
  94. Rivardo F., Turner R.J., Allegrone G., Ceri H., Martinotti M.G.. Anti-adhesion activity of two biosurfactants produced by Bacillus spp. prevents biofilm formation of human bacterial pathogens.. Appl. Microbiol. Biotechnol. 2009;83:541–553.
    doi: 10.1007/s00253-009-1987-7pubmed: 19343338google scholar: lookup

Citations

This article has been cited 5 times.
  1. Styková E, Bedlovičová Z, Šurín Hudáková N, Karaffová V, Kalocsaiová K, Bhide M. Characterization of a newly isolated biosurfactant fengycin produced by Heyndrickxia coagulans strain. AMB Express 2025 Sep 30;15(1):139.
    doi: 10.1186/s13568-025-01942-1pubmed: 41026384google scholar: lookup
  2. Styková E, Valocký I, Kačírová J, Fecskeová LK. Microbiological effect of topically applied Weissella cibaria on equine pastern dermatitis. Front Vet Sci 2024;11:1493756.
    doi: 10.3389/fvets.2024.1493756pubmed: 39834920google scholar: lookup
  3. Lawhon SD, Burbick CR, Krueger T, Ruiz-Reyes E, Munson E. An update on novel taxa and revised taxonomic status of bacteria isolated from domestic companion and agricultural animals described in 2023. J Clin Microbiol 2024 Dec 11;62(12):e0104124.
    doi: 10.1128/jcm.01041-24pubmed: 39495011google scholar: lookup
  4. Subbarayudu S, Namasivayam SKR, Arockiaraj J. Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management. Curr Microbiol 2024 Sep 6;81(10):346.
    doi: 10.1007/s00284-024-03875-7pubmed: 39240286google scholar: lookup
  5. Fusco V, Chieffi D, Fanelli F, Montemurro M, Rizzello CG, Franz CMAP. The Weissella and Periweissella genera: up-to-date taxonomy, ecology, safety, biotechnological, and probiotic potential. Front Microbiol 2023;14:1289937.
    doi: 10.3389/fmicb.2023.1289937pubmed: 38169702google scholar: lookup
Subscribe to our newsletter
Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.